Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,872 | -52,293 | -25,473 | -100,507 | -75,332 |
| Depreciation Amortization | 126 | 86 | 43 | 134 | 99 |
| Accounts payable and accrued liabilities | -927 | -896 | -2,083 | 3,145 | 871 |
| Other Working Capital | 3,510 | 1,773 | 1,559 | 564 | 138 |
| Other Operating Activity | 8,638 | 4,945 | 4,178 | 11,898 | 12,421 |
| Operating Cash Flow | $-66,525 | $-46,385 | $-21,776 | $-84,766 | $-61,803 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150 | -83 | -47 | -264 | -261 |
| Investing Cash Flow | $-150 | $-83 | $-47 | $-264 | $-261 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 123 | 123 | 0 | 268 | 191 |
| Other Financing Activity | 65,395 | 65,395 | 0 | 74,273 | 74,273 |
| Financing Cash Flow | $65,518 | $65,518 | $0 | $74,541 | $74,464 |
| Exchange Rate Effect | 621 | 592 | 459 | -517 | -3 |
| Beginning Cash Position | 35,668 | 35,668 | 35,668 | 46,674 | 46,674 |
| End Cash Position | 35,132 | 55,310 | 14,304 | 35,668 | 59,071 |
| Net Cash Flow | $-536 | $19,642 | $-21,364 | $-11,006 | $12,397 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,525 | -46,385 | -21,776 | -84,766 | -61,803 |
| Capital Expenditure | -150 | -83 | -47 | -264 | -261 |
| Free Cash Flow | -66,675 | -46,468 | -21,823 | -85,030 | -62,064 |